Mapping lymph nodes in early ovarian cancer surgery
Treatments studied
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests a new technique using special dye to help surgeons find and remove the first lymph nodes that drain fluid from ovarian tumors during surgery. This might help doctors better stage your cancer and plan your treatment more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 90 years old
- You have an ovarian mass (one or both sides) that needs surgery
- Frozen section (quick lab test during surgery) confirms malignant or borderline epithelial ovarian cancer
- Imaging (PET, MRI, or CT) shows no signs of advanced cancer spread
- You have not had previous lymph node removal surgery or radiation therapy
- You are not allergic to indocyanine green dye or iodine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a technique to find and remove only the lymph nodes that might contain cancer cells during surgery for early-stage ovarian cancer. It uses a special dye to highlight the sentinel lymph nodes, which may reduce side effects while still checking for spread.
This study checks whether doctors can find the first lymph node(s) where ovarian cancer may spread using two dyes (a radioactive tracer and a green dye). It may help surgeons do more precise staging and treatment planning.
This trial tests whether injecting a dye called indocyanine green (ICG) in different spots can better find sentinel lymph nodes during surgery for endometrial cancer. It may help doctors remove fewer nodes and reduce side effects.
This study tests a way to check for cancer spread in the lymph nodes of the pelvis during surgery for early-stage ovarian cancer. It uses a special dye and tracer to find the first lymph node that drains from the tumor.
This trial tests if a special dye (indocyanine green) can find the first lymph nodes (sentinel nodes) during mastectomy. It may help improve staging for women with early breast cancer who need or choose mastectomy.
This trial tests a dye called ICG to find the first lymph nodes that might have cancer cells. It is for women with early-stage vulvar cancer that has not spread to the lymph nodes.
Hear when a new Epithelial Ovarian Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.